These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25414036)

  • 1. Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states.
    Little JW; Ford A; Symons-Liguori AM; Chen Z; Janes K; Doyle T; Xie J; Luongo L; Tosh DK; Maione S; Bannister K; Dickenson AH; Vanderah TW; Porreca F; Jacobson KA; Salvemini D
    Brain; 2015 Jan; 138(Pt 1):28-35. PubMed ID: 25414036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Morphine-Induced Changes in Signaling at the A
    Doyle TM; Largent-Milnes TM; Chen Z; Staikopoulos V; Esposito E; Dalgarno R; Fan C; Tosh DK; Cuzzocrea S; Jacobson KA; Trang T; Hutchinson MR; Bennett GJ; Vanderah TW; Salvemini D
    J Pharmacol Exp Ther; 2020 Aug; 374(2):331-341. PubMed ID: 32434943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A3 receptor activation inhibits pronociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neurons.
    Coppi E; Cherchi F; Fusco I; Failli P; Vona A; Dettori I; Gaviano L; Lucarini E; Jacobson KA; Tosh DK; Salvemini D; Ghelardini C; Pedata F; Di Cesare Mannelli L; Pugliese AM
    Pain; 2019 May; 160(5):1103-1118. PubMed ID: 31008816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced pain is promoted by enhanced spinal adenosine kinase levels through astrocyte-dependent mechanisms.
    Wahlman C; Doyle TM; Little JW; Luongo L; Janes K; Chen Z; Esposito E; Tosh DK; Cuzzocrea S; Jacobson KA; Salvemini D
    Pain; 2018 Jun; 159(6):1025-1034. PubMed ID: 29419652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
    Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
    Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10.
    Durante M; Squillace S; Lauro F; Giancotti LA; Coppi E; Cherchi F; Di Cesare Mannelli L; Ghelardini C; Kolar G; Wahlman C; Opejin A; Xiao C; Reitman ML; Tosh DK; Hawiger D; Jacobson KA; Salvemini D
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33621215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of the GABA to KCC2 signaling pathway contributes to the analgesic effects of A3AR agonists in neuropathic pain.
    Ford A; Castonguay A; Cottet M; Little JW; Chen Z; Symons-Liguori AM; Doyle T; Egan TM; Vanderah TW; De Koninck Y; Tosh DK; Jacobson KA; Salvemini D
    J Neurosci; 2015 Apr; 35(15):6057-67. PubMed ID: 25878279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A
    Terayama R; Tabata M; Maruhama K; Iida S
    Exp Brain Res; 2018 Dec; 236(12):3203-3213. PubMed ID: 30206669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Histamine H
    Micheli L; Durante M; Lucarini E; Sgambellone S; Lucarini L; Di Cesare Mannelli L; Ghelardini C; Masini E
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amitriptyline inhibits the MAPK/ERK and CREB pathways and proinflammatory cytokines through A3AR activation in rat neuropathic pain models.
    Kim Y; Kwon SY; Jung HS; Park YJ; Kim YS; In JH; Choi JW; Kim JA; Joo JD
    Korean J Anesthesiol; 2019 Feb; 72(1):60-67. PubMed ID: 29969887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
    Stockstill K; Wahlman C; Braden K; Chen Z; Yosten GL; Tosh DK; Jacobson KA; Doyle TM; Samson WK; Salvemini D
    Pain; 2020 Jan; 161(1):177-184. PubMed ID: 31490328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
    Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H
    Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures.
    Parenti C; Turnaturi R; Aricò G; Gramowski-Voss A; Schroeder OH; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
    Neuropharmacology; 2013 Aug; 71():70-82. PubMed ID: 23541722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of A3 adenosine receptor in diabetic neuropathy.
    Yan H; Zhang E; Feng C; Zhao X
    J Neurosci Res; 2016 Oct; 94(10):936-46. PubMed ID: 27319979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The control of alternative splicing by SRSF1 in myelinated afferents contributes to the development of neuropathic pain.
    Hulse RP; Drake RA; Bates DO; Donaldson LF
    Neurobiol Dis; 2016 Dec; 96():186-200. PubMed ID: 27616424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration.
    Fedorova IM; Jacobson MA; Basile A; Jacobson KA
    Cell Mol Neurobiol; 2003 Jun; 23(3):431-47. PubMed ID: 12825837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A
    Coppi E; Cherchi F; Lucarini E; Ghelardini C; Pedata F; Jacobson KA; Di Cesare Mannelli L; Pugliese AM; Salvemini D
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
    Janes K; Wahlman C; Little JW; Doyle T; Tosh DK; Jacobson KA; Salvemini D
    Brain Behav Immun; 2015 Feb; 44():91-9. PubMed ID: 25220279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the A
    Singh AK; Mahalingam R; Squillace S; Jacobson KA; Tosh DK; Dharmaraj S; Farr SA; Kavelaars A; Salvemini D; Heijnen CJ
    Acta Neuropathol Commun; 2022 Jan; 10(1):11. PubMed ID: 35093182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
    Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.